ArticleJournal of medicinal chemistry2015

Oral Selective Estrogen Receptor Downregulators (SERDs), a Breakthrough Endocrine Therapy for Breast Cancer.

Donald P McDonnell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.